title: Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine.
abstract: We compared the cardiac electrophysiological actions of two types of H1-receptor antagonists--the piperidines, astemizole and terfenadine, and the nonpiperidines, chlorpheniramine and pyrilamine-in vitro in guinea pig ventricular myocytes and in vivo in chloralose-anesthetized dogs. Astemizole and terfenadine significantly increased action potential duration of guinea pig myocytes. This concentration-dependent prolongation of action potential duration was reverse frequency dependent and led to development of early afterdepolarizations, which occurred more frequently at higher concentrations and slower pacing frequencies. Astemizole and terfenadine potently blocked the rapidly activating component of the delayed rectifier, IKr, with IC50 values of 1.5 and 50 nmol/L, respectively. At 10 mumol/L, terfenadine but not astemizole blocked the slowly activating component of the delayed rectifier, IKs (58.4 +/- 3.1%), and the inward rectifier, IK1 (20.5 +/- 3.4%). Chlorpheniramine and pyrilamine blocked IKr relatively weakly (IC50 = 1.6 and 1.1 mumol/L, respectively) and IKs and IK1 less than 20% at 10 mumol/L. Astemizole and terfenadine (1.0 to 3.0 mg/kg IV) significantly prolonged the QTc interval and ventricular effective refractory period in vivo. Chlorpheniramine and pyrilamine (< or = 3.0 mg/kg) did not significantly affect these parameters. Block of repolarizing K+ currents, particularly IK1, by astemizole and terfenadine produces reverse rate-dependent prolongation of action potential duration and development of early afterdepolarizations, delays ventricular repolarization, and may underlie the development of torsade de pointes ventricular arrhythmias observed with the use and abuse of these agents.
authors.affiliation: Department of Pharmacology, Merck Research Laboratories, West Point, Pa 19486.
authors.forename: J J
authors.initials: JJ
authors.lastname: Salata
authors.forename: N K
authors.initials: NK
authors.lastname: Jurkiewicz
authors.forename: A A
authors.initials: AA
authors.lastname: Wallace
authors.forename: R F
authors.initials: RF
authors.lastname: Stupienski
authors.forename: P J
authors.initials: PJ
authors.lastname: Guinosso
authors.forename: J J
authors.initials: JJ
authors.lastname: Lynch
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D016589:Astemizole / Q000494:pharmacology*; D002744:Chlorpheniramine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D066298:In Vitro Techniques; D015221:Potassium Channels / Q000187:drug effects; D011738:Pyrilamine / Q000494:pharmacology*; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D016593:Terfenadine / Q000494:pharmacology*
chemical_list: D015221:Potassium Channels; D002744:Chlorpheniramine; D016593:Terfenadine; D016589:Astemizole; D011738:Pyrilamine